Brooks Laboratories Stock Hits Upper Circuit Limit with Intraday High of Rs 138.34

Brooks Laboratories Ltd, a microcap player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today as it hit its upper circuit limit. The stock reached an intraday high of Rs 138.34, reflecting a notable increase of 4.99% from its previous trading session. This upward movement comes after a challenging period, marking a trend reversal following 13 consecutive days of decline.
The stock's last traded price (LTP) stands at Rs 137.5, with a change of Rs 5.74, translating to a percentage change of 4.36%. The price band for the day was set at 5%, indicating a robust trading environment. Total traded volume reached approximately 0.46061 lakh shares, contributing to a turnover of Rs 0.617 crore.

In terms of performance metrics, Brooks Laboratories outperformed its sector by 4.24%, while the stock's 1-day return was recorded at 2.95%. Despite trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, the stock has seen a rise in investor participation, with delivery volume increasing by 21.14% compared to the 5-day average.

Overall, Brooks Laboratories Ltd's performance today highlights a significant rebound, reflecting a positive shift in market sentiment.